Shape

Intrapharm

Specialist pharmaceutical company

Company bio

BGF invested in Intrapharm in August 2014 and supported the company's acquisition of three specialist pharma companies: Peckforton Pharmaceuticals, Alvedon, Aquamax. Following a period of sustained growth, with revenues increasing from £4m p.a. at the point of BGF’s investment to £12m in November 2015, the business was acquired by German pharmaceutical company RIEMSER Pharma GmbH. BGF exited its minority equity stake in the business, with all shareholders realising a strong return.

Company
information

Head office

Maidenhead

 

CEO

Kevin James

 

COO

Shafiq Choudhary

 

Website

intrapharmlabs.com

BGF office

Reading

 

BGF team

James Austin

Greg Norman

 

Investment between

Aug 2014 – Nov 2015

 

Total BGF investment

£2m

Sign-up to BGF investment alerts